Loading chat...

HI SR102

Resolution

Status

Introduced

3/9/2018

Primary Sponsor

Kalani English

Click for details

Origin

Senate

2018 Regular Session

AI Summary

  • Urges the United States Food and Drug Administration to expedite approval of new nonprescription sunscreen active ingredients that have been used safely and effectively globally
  • Notes that pending Time and Extent Applications from the sunscreen industry seek FDA approval of nonprescription sunscreen active ingredients, but none have been approved as of the resolution's introduction
  • States that delays in FDA approval have hindered the sunscreen industry's ability to innovate and bring alternative ingredients to the U.S. market
  • Calls on the FDA to work collaboratively with stakeholders to increase consumer access and choice in sunscreen products while enabling industry innovation
  • Directs transmission of certified copies to the FDA Commissioner, U.S. congressional leadership, Hawaii's congressional delegation, and presiding officers of all state legislatures

Legislative Description

Urging The United States Food And Drug Administration To Expedite The Approval Of New Nonprescription Sunscreen Active Ingredients For Use In The United States.

Sunscreen Ingredients

Last Action

Referred to CPH.

3/16/2018

Committee Referrals

Commerce, Consumer Protection, and Health3/16/2018

Full Bill Text

No bill text available